Assessment of Bisphosphonates Use As Adjuvant Therapy in Breast Cancer von Abu-Taleb, F.M., El-Zawahry, H.M., Zekri, Z.K., Gaafar, R.M.M., Al Lahloubi, N.M.A., Zakhari, N., Elfarargy, O., Alnagar, A. Abdel Raheem

Volltext

304PASSESSMENT OF BISPHOSPHONATES USE AS ADJUVANT THERAPY IN BREAST CANCER von Abu-Taleb, F.M., El-Zawahry, H.M., Zekri, Z.K., Gaafar, R.M.M., Al Lahloubi, N.M.A., Zakhari, N., Elfarargy, O., Alnagar, A. Abdel Raheem

Volltext

Full donor chimerism without graft-versus-host disease: the key factor for maximum benefit of pre-emptive donor lymphocyte infusions (pDLI) von Feliu, Jesus, Potter, Victoria, Grimaldi, Francesco, Clay, Jennifer, Floro, Lajos, Saha, Chandan, Barber, Linda, Orti, Guillermo, Alnagar, Ahmad AbdelRaheem, Garcia-Muñoz, Ricardo, Kenyon, Michelle, Krishnamurthy, Pramila, de Lavallade, Hugues, Raj, Kavita, McLornan, Donal, Pagliuca, Antonio, Mufti, Ghulam J.

Volltext